Neurizon Therapeutics Limited Stock: price and insider trades · Australia

Neurizon Therapeutics Limited, classified in the Health Care sector, is a listed company. Its insiders report their share dealings to ASX. Between 24 October 2025 and 24 October 2026, 4 insiders published 5 filings.

Both sides are active: 2 purchases worth €39k and 1 sale, from 2 insiders and 1 insider respectively. The totals exclude 1 filing filed without an amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. On the buying side, the filings list 2 senior executives among the declarants. Marcus Hughes filed the largest purchase, €21k, on 30 June 2026, which represents 0.055% of the company's market value.

The last purchase on record was published on 17 September 2026, which is 52 days ago.

For context, the typical company on the same exchange (median of 1,596 companies) published 4 filings over the same period, against 5 filings here. Over the whole record (from 2026), the tally stands at 2 purchases and 1 sale.

Elsewhere in the same sector, our signals recently picked up insider purchases at Dynavox Group AB and EssilorLuxottica. These figures are compiled from regulatory filings published by ASX. They describe what insiders did and are not a recommendation.